Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #2996
Attaches drug safety information from the Medicines and Healthcare Products Regulatory Agency (MHRA) for onward transmission.
Drug alert 17: Milpharm Limited are recalling all unexpired stock of Fluoxetine 20mg Capsules product in Karib Kemi Pharm Limited livery only (batches beginning with ‘T’) due to serious Good Manufacturing Practice (GMP) deficiencies.
Drug alert 18: Karib Kemi Pharm Limited are recalling some products (Doxazosin 2mg and 4mg Tablets, Fluoxetine 20mg Capsules) due to serious Good Manufacturing Practice (GMP) deficiencies.
Drug alert 19: LPC Medical (UK) Limited are recalling all unexpired stock of some products (Co-Amilozide 5/50 Tablets, Metformin 500mg Tablets, Metformin 850mg Tablets, Naproxen 250mg Tablets, Naproxen 500mg Tablets) in Karib Kemi Pharm livery only due to serious Good Manufacturing Practice (GMP) deficiencies.
Drug alert 20: Sandoz Limited are recalling some products (Baclofen 10mg Tablets, Fluoxetine 20mg Capsules, Metformin 500mg Tablets, Metformin 850mg Tablets) due to serious Good Manufacturing Practice (GMP) deficiencies.
Drug alert 21: Strandhaven Limited are recalling Amlodipine 5mg and 10mg Tablets due to serious Good Manufacturing Practice (GMP) deficiencies.
Click to go back to homepage